#Blockchain #biotech #Shineco

Shineco Agriculture Unveils Groundbreaking On-Chain Tokenization Platform

On August 20, 2025, Shineco Inc., a leader in induced pluripotent stem cell (iPSC) technology, announced their pioneering launch of the world's first on-chain cellular asset tokenization platform through a strategic partnership with Plus Me Limited. This innovative initiative aims to transform the biological cellular asset landscape by enabling blockchain-based tokenization of biological materials, ensuring seamless global transfers and standardized custody mechanisms. This groundbreaking technology represents a revolutionary shift in the cell therapy industry by creating an unprecedented 'Asset On-Chaining + Application Scenarios' model.

This partnership involves the deployment of Shineco's compliant mesenchymal stem cells (MSCs) on the Ethereum blockchain. Plus Me will oversee full lifecycle digital custody, leveraging smart contracts for secure and immutable asset ownership rights. Each cellular asset will receive its unique non-fungible digital identifier (NFID), ensuring regulated traceability in compliance with industry standards. Through on-chain hashing, the validity and compliance of these assets will be cryptographically enforced, making traditional issues of product provenance a relic of the past.

As part of this comprehensive approach, Plus Me will issue ERC-1400/ ERC-20 compliant security tokens, known as